Zydus Lifesciences Limited Meloxicam Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Meloxicam Export Records India — #3 Exporter, 184 Shipments, $6.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Meloxicam

India Pharmaceutical Trade Intelligence

$199.4M277 Suppliers100 CountriesHS 30049066

ExportsIndia → UNITED STATES86.3%India → SERBIA3.0%

ImportsUNITED STATES → India$1.1M GERMANY → India$19.9K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Zydus Lifesciences Limited — Meloxicam Exporter #3 | $6.2M Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Meloxicam Exporter Profile

Indian Pharmaceutical Exporter · #3 for Meloxicam · $6.2M export value · DGFT Verified

Zydus Lifesciences Limited is the #3 Indian exporter of Meloxicam with $6.2M in export value and 184 verified shipments. Zydus Lifesciences Limited holds a 3.1% market share in Meloxicam exports across 4 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Meloxicam Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Meloxicam export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Meloxicam?

Country	Value	Shipments	Share
UNITED STATES	$4.3M	148	90.8%
THAILAND	$284.9K	16	6.0%
SOUTH AFRICA	$122.1K	19	2.6%
BRAZIL	$33.3K	1	0.7%

Who Are the Top Buyers of Meloxicam from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$4.1M	141
PRIORITY HEALTHCARE DISTRIBUTION	UNITED STATES	$205.9K	6
PHARMALAND (1982) CO. LTD	THAILAND	$156.6K	9
ZYDUS HEALTHCARE SA (PTY) LTD	SOUTH AFRICA	$106.4K	16
PHARMALAND (1982) CO.LTD	THAILAND	$81.8K	4
PRIORITY HEALTHCARE DISTRIBUTION DB	UNITED STATES	$50.0K	1
PHARMALAND 1982 CO LTD	THAILAND	$36.5K	2
ZYDUS NIKKHO FARMACEUTICA LTDA	BRAZIL	$33.3K	1
ZYDUS HEALTHCARE SA (PTY) LIMITED	SOUTH AFRICA	$15.7K	3
PHARMALAND (1982) CO.LIMITED	THAILAND	$9.9K	1

Zydus Lifesciences Limited supplies Meloxicam to 10 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by PRIORITY HEALTHCARE DISTRIBUTION (UNITED STATES) and PHARMALAND (1982) CO. LTD (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Meloxicam Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA MEDICINE FOR HUMAN USE-MELOXICAM	$574.5K	14
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1X500-QTY-22,944.000 PAC-AS PER INVNOS	$148.9K	6
MELOXICAM TABLET USP 15 MG 1 X 500 OTHER DETAILS AS PER INV AND PLIST	$124.8K	3
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1X500 -QTY-37,956.000-PAC	$120.6K	3
MELOXICAM TABS USP 15 MG 1x500 (OTHER DETAILS AS PER INV & P.LIST)	$100.0K	2
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1X500-QTY-30,972.000-PAC	$97.7K	3
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1X500-QTY-30,600.000-PAC	$96.4K	3
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 7.5 MG 1X500-QTY-31032.000 PAC-AS PER INVNOS	$83.1K	3
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 7.5 MG 1X100-QTY-75,888.000 PAC-AS PER INVNOS	$82.9K	6
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 7.5 MG 1X500 -QTY-30,744.000-PAC	$79.7K	3

Zydus Lifesciences Limited exports 113 distinct Meloxicam formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA MEDICINE FOR HUMAN USE-MELOXICAM with 14 shipments worth $574.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Zydus Lifesciences Limited Compare to Nearest Meloxicam Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	CIPLA LIMITED	$28.7M	889	8	$32.3K
1	UNICHEM LABORATORIES LIMITED	$18.4M	368	13	$50.0K
3	ZYDUS LIFESCIENCES LIMITED ★	$6.2M	184	4	$33.7K
4	LUPIN LIMITED	$1.5M	30	1	$50.0K
7	AUROBINDO PHARMA LTD	$1.1M	127	13	$8.4K

Zydus Lifesciences Limited ranks #3 among 277 Indian Meloxicam exporters. Average shipment value of $33.7K compared to the market average of $227.2K. The closest competitors by value are CIPLA LIMITED and UNICHEM LABORATORIES LIMITED.

Which Indian Ports Ship Meloxicam Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	583	17.7%
JNPT/ NHAVA SHEVA SEA	374	11.3%
SAHAR AIR	370	11.2%
SAHAR AIR CARGO ACC (INBOM4)	276	8.4%
JNPT	242	7.3%
NHAVA SHEVA	147	4.5%
MUNDRA SEA	137	4.2%
Bombay Air	117	3.5%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Meloxicam Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Meloxicam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 184 individual customs records matching Zydus Lifesciences Limited exporting Meloxicam, covering 113 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 566+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Meloxicam

Meloxicam

Zydus Lifesciences Limited — Meloxicam Exporter Profile

Zydus Lifesciences Limited — Meloxicam Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Meloxicam?

Who Are the Top Buyers of Meloxicam from Zydus Lifesciences Limited?

What Is India's Total Meloxicam Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Meloxicam Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Meloxicam Exporters?

What Meloxicam Formulations Does Zydus Lifesciences Limited Export?

Regulatory Requirements: Exporting Meloxicam to Key Markets

United States — FDA

South Africa — SAHPRA

How Does Zydus Lifesciences Limited Compare to Nearest Meloxicam Exporters?

Which Indian Ports Ship Meloxicam Exports?

What Other Analgesics & Antipyretics Products Does Zydus Lifesciences Limited Export?

Meloxicam — Export Intelligence Video

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Meloxicam Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Meloxicam Export Data from Zydus Lifesciences Limited

Meloxicam Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source